Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk
DAIC
JANUARY 23, 2024
21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 2015;45(3):341-350.
111 
Let's personalize your content